McKesson Corporation $MCK Shares Acquired by Mufg Securities Americas Inc.

Mufg Securities Americas Inc. increased its position in McKesson Corporation (NYSE:MCK) by 25.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 2,773 shares of the company’s stock after buying an additional 555 shares during the period. Mufg Securities Americas Inc.’s holdings in McKesson were worth $2,032,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Nuveen LLC acquired a new stake in McKesson during the first quarter worth about $475,235,000. Wellington Management Group LLP grew its holdings in shares of McKesson by 4,559.6% during the 1st quarter. Wellington Management Group LLP now owns 427,703 shares of the company’s stock worth $287,840,000 after purchasing an additional 418,524 shares during the period. Boston Partners increased its position in McKesson by 33.3% during the 1st quarter. Boston Partners now owns 1,461,785 shares of the company’s stock worth $984,927,000 after purchasing an additional 365,484 shares in the last quarter. Voya Investment Management LLC increased its position in McKesson by 92.3% during the 1st quarter. Voya Investment Management LLC now owns 650,851 shares of the company’s stock worth $437,760,000 after purchasing an additional 312,473 shares in the last quarter. Finally, Acadian Asset Management LLC raised its holdings in McKesson by 68.0% in the second quarter. Acadian Asset Management LLC now owns 636,596 shares of the company’s stock valued at $466,441,000 after buying an additional 257,670 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Trading Up 2.0%

MCK opened at $866.13 on Friday. McKesson Corporation has a twelve month low of $558.13 and a twelve month high of $869.74. The firm has a market cap of $106.90 billion, a price-to-earnings ratio of 34.53, a PEG ratio of 1.46 and a beta of 0.51. The company has a fifty day simple moving average of $788.46 and a 200 day simple moving average of $734.59.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $9.86 earnings per share for the quarter, beating analysts’ consensus estimates of $8.84 by $1.02. McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The company had revenue of $103.15 billion during the quarter, compared to analysts’ expectations of $103.80 billion. During the same period in the prior year, the company posted $7.07 EPS. The firm’s revenue for the quarter was up 10.2% on a year-over-year basis. On average, analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Monday, December 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, December 1st. McKesson’s payout ratio is 10.21%.

Insider Transactions at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the stock in a transaction on Friday, November 7th. The shares were sold at an average price of $861.63, for a total transaction of $283,476.27. Following the transaction, the chief accounting officer directly owned 328 shares in the company, valued at $282,614.64. This represents a 50.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.08% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on MCK. Wells Fargo & Company boosted their price objective on shares of McKesson from $816.00 to $914.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Mizuho upped their price target on shares of McKesson from $750.00 to $770.00 and gave the stock a “neutral” rating in a research report on Wednesday, September 24th. JPMorgan Chase & Co. raised their price objective on McKesson from $821.00 to $853.00 and gave the company an “overweight” rating in a research report on Friday, September 26th. Finally, TD Cowen boosted their price objective on McKesson from $830.00 to $864.00 and gave the stock a “buy” rating in a research note on Wednesday, September 24th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $887.69.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.